EctoPharma believes it will be able to achieve a feat that has defeated some of the world’s best pharmaceutical brains with a drug that should boost the body’s ability to fight the cancer.
- Text size
Pioneering cancer treatment could generate annual sales of $500m
A Scottish pharmaceuticals firm hopes to be able to develop a pioneering treatment for pancreatic cancer after signing deals that will allow it to combine the technologies developed by two world-leading research institutions.
